"Run Away" from MannKind (MNKD) - David Kliff

August 12, 2011 11:29 AM EDT
According to theStreet.com's Adam Feuerstein, David Kliff of Diabetic Investor is telling his clients to "run away as fast as you can" from MannKind Corp. (Nasdaq: MNKD) on today's spike.

Shares of MannKind are up over 20 percent today after confirming two AFREZZA studies with the FDA.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Add Your Comment